Matches in Wikidata for { <http://www.wikidata.org/entity/Q83111935> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q83111935 description "2012 թվականին հրատարակված գիտական հոդված" @default.
- Q83111935 description "artikull shkencor i botuar më 01 janar 2012" @default.
- Q83111935 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q83111935 description "im Jahr 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83111935 description "scientific article published on 01 January 2012" @default.
- Q83111935 description "wetenschappelijk artikel" @default.
- Q83111935 description "наукова стаття, опублікована в січні 2012" @default.
- Q83111935 description "научна статия" @default.
- Q83111935 name "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 name "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 name "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 type Item @default.
- Q83111935 label "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 label "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 label "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 prefLabel "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 prefLabel "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 prefLabel "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 P1433 Q83111935-CED1C3DE-CC60-4A7E-98B2-F5A13A2D584D @default.
- Q83111935 P1476 Q83111935-86B9A7FC-2A06-4275-AA75-4CA791FF7906 @default.
- Q83111935 P2093 Q83111935-5CFBDF33-1F1B-4F6E-962E-7ED0E4BCA2FA @default.
- Q83111935 P2093 Q83111935-B89530C9-A931-4E13-9DD5-8A3EF5C52DC7 @default.
- Q83111935 P2093 Q83111935-D3BAB43A-8DB0-4777-8FDD-47100BB686F1 @default.
- Q83111935 P304 Q83111935-8D4DE6B0-F079-4392-AEBE-27BC23FB8362 @default.
- Q83111935 P31 Q83111935-A01D59F4-AF17-4B82-B4C6-8EB13F4DEFBA @default.
- Q83111935 P356 Q83111935-76A4DB00-2980-4776-BFA7-0D05C5407DEC @default.
- Q83111935 P433 Q83111935-9A090ECC-6658-460E-8BDD-29F4BE0C52A0 @default.
- Q83111935 P478 Q83111935-CA01C85E-957A-45B5-B826-DDE58E107764 @default.
- Q83111935 P50 Q83111935-9146C498-28AB-43BE-AD56-00C15C995291 @default.
- Q83111935 P577 Q83111935-1F3C3AE5-FA6F-4026-BFA9-AFA8753B72C7 @default.
- Q83111935 P698 Q83111935-3324B46C-CA90-4475-AC9B-D291268A3F43 @default.
- Q83111935 P921 Q83111935-89D1EE8C-EFF0-4C3C-B662-0F9B3FF827D7 @default.
- Q83111935 P356 CP201615 @default.
- Q83111935 P698 22192639 @default.
- Q83111935 P1433 Q15751305 @default.
- Q83111935 P1476 "Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico" @default.
- Q83111935 P2093 "Dolores Mino-León" @default.
- Q83111935 P2093 "Sergio Flores-Hernández" @default.
- Q83111935 P2093 "Svetlana V Doubova" @default.
- Q83111935 P304 "1-9" @default.
- Q83111935 P31 Q13442814 @default.
- Q83111935 P356 "10.5414/CP201615" @default.
- Q83111935 P433 "1" @default.
- Q83111935 P478 "50" @default.
- Q83111935 P50 Q96579057 @default.
- Q83111935 P577 "2012-01-01T00:00:00Z" @default.
- Q83111935 P698 "22192639" @default.
- Q83111935 P921 Q424771 @default.